[1]
Allaqaband, S.M. and Naqashbandi, F. 2022. Reporting Cases of Telogen Effluvium as a sequelae of COVID‐19 Infection. Journal of Drug Delivery and Therapeutics. 12, 1 (Jan. 2022), 149–150. DOI:https://doi.org/10.22270/jddt.v12i1.5309.